ICON Public Limited Company Stock
ICON Public Limited Company
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- Ireland
- CEO
- Barry Balfe
- Employees
- 40,200
- Market cap
- $13.1 B
- IPO
- 15/05/1998
ICON Public Limited Company is a clinical research organization that provides outsourced development and commercialization services. The company is headquartered in Dublin, Ireland, and was incorporated in 1989. Its operations span across Ireland, the rest of Europe, the United States, and international markets. The…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
ICON Public Limited Company stock: price history
1D
-2.8%
1W
+3.7%
1M
-2.2%
6M
+42.2%
YTD
-6.6%
1Y
-9.7%
2Y
-42.0%
5Y
-38.1%
10Y
+120.8%
Next earnings date
Next earnings date
27/10/2026 (in 10 days)
Volatility around earnings
~57% stronger price swings than usual
ICON Public Limited Company stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about ICON Public Limited Company
Analyst assessment of ICON Public Limited Company
PRICE TARGET LOW
US$105.00
CONSENSUS
US$173.82
MEDIAN
US$185.00
PRICE TARGET HIGH
US$207.00
0
STRONG BUY
17
BUY
11
HOLD
2
SELL
0
STRONG SELL
30
TOTAL · Buy
As of: 18/09/2026
ICON Public Limited Company stock metrics
P/E
39.67
P/B
1.39
EV/EBITDA
12.61
RETURN ON EQUITY
0.8%
NET MARGIN
3.5%
DEBT/EQUITY
0.37
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.0%
FLOAT SHARES
76,346,396
AVG. DAILY VOLUME (30D)
989,008
Insider transactions (SEC)
CLIMAX JOHN DR
CLIMAX JOHN DR
McCague Eugene Pacelli
Murphy Ronan Martin
Murphy Ronan Martin
Institutional holders
Dividends & Stock splits
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about ICON Public Limited Company stock
What does ICON Public Limited Company do?
ICON Public Limited Company is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in Ireland.
The CEO is Barry Balfe, the company employs around 40,200 people.
The IPO was on 15/05/1998; the stock trades on NASDAQ under the ticker ICLR.
What do analysts say about ICON Public Limited Company stock?
30 analysts rate the stock, the consensus is Buy (as of 18/09/2026).
The average price target is US$173.82, ranging from US$105.00 to US$207.00, with a median of US$185.00.
This is an external assessment, not a statement by Market Jury.
When does ICON Public Limited Company report next?
The next earnings date is 27/10/2026.
Around past earnings, price swings were roughly 57% stronger than usual.
Does ICON Public Limited Company pay a dividend?
No, ICON Public Limited Company currently does not pay a dividend.
Which stocks are comparable to ICON Public Limited Company?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get ICON Public Limited Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess ICON Public Limited Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.